李俊旭：男，1977年4月生，特聘教授，药理学博士后、博士生导师。2000年本科毕业于滨州医学院临床医学专业，2000年至2005年在北京大学硕博连读，获药理学博士学位；2005年至2008年在美国德克萨斯大学圣安东尼奥医学中心从事博士后研究；2008年至2010年在美国德克萨斯大学圣安东尼奥医学中心工作，任instructor；2010年起在美国纽约州立大学布法罗分校工作，现任助理教授（tenure-track）。多年从事疼痛和药物成瘾方面的研究工作，是行为药理学领域的专家。主持布法罗研究基金会、美国国立卫生研究院（NIH）等多项研究，发表研究论文40多篇。获包括美国药理学与实验治疗学会（ASPET）旅行奖、最佳论文奖、美国药物滥用问题学会（CPDD）青年科学家奖在内的多个奖项；现为Nature Scientific Reports;International Journal of Physiology, Pathophysiology and Pharmacology杂志编委，应邀作为二十多家国际学术杂志和欧洲研究基金资助机构、美国 Vanderbilt大学等的审稿人。

　　通讯作者（或第一作者）代表作：

　　25. Pain and depression comorbidity: a preclinical perspective. Behav Brain Res (Epub) 2014 May 2. pii: S0166-4328(14)00269-1. PMID: 2479783

　　24. Effects of the cannabinoid CB1 receptor allosteric modulator ORG 27569 on reinstatement of cocaine- and methamphetamine-seeking behavior in rats. Drug Alcohol Depend 2014 (epub)

　　23. Antinociceptive effects of curcumin in a rat model of postoperative pain. Sci Rep 2014 May 12; 4:4932.

　　22. Trace amines and cocaine abuse. ACS Chem Neurosci 2014 Jul 16; 5(7):497-8.

　　21. Effects of the trace amine associated receptor 1 agonist RO5263397 on abuse-related effects of cocaine in rats. Neuropsychopharmacology 2014 Sep; 39(10):2309-16.

　　20. The trace amine associated receptor 1 agonist RO5263397 attenuates the induction of cocaine behavioral sensitization in rats. Neurosci Lett 2014 Apr 30; 566:67-71.

　　19. Behavioral effects of the imidazoline I2 receptor ligand BU99006 in rats. Behav Pharmacol 2014 Apr; 25(2):130-

　　18. Anti-hyperalgesic effects of imidazoline I2 receptor ligands in rat models of inflammatory and neuropathic pain. Br J Pharmacol 2014 Mar; 171(6):1580-90.

　　17. Gender difference in epileptogenic effects of 2-BFI and BU224 in mice. Eur J Pharmacol 2013 Oct 15; 718(1-3):81-6.

　　16. The application of conditioning paradigms in the measurement of pain. Eur J Pharmacol 2013 Sep 15; 716(1-3):158-68.

　　15. The GPR88 receptor agonist 2-PCCA does not alter the behavioral effects of methamphetamine in rats. Eur J Pharmacol 2013 Jan 5; 698(1-3):272-7.

　　14. Modification of the behavioral effects of morphine in rats by serotonin 5-HT?A and 5-HT?A receptor agonists: antinociception, drug discrimination, and locomotor activity. Psychopharmacology 2013 Feb; 225(4):791-801.

　　13. Interactions between ?9-THC and heroin: self-administration in rhesus monkeys. Behav Pharmacol 2012 Dec; 23(8):754-61.

　　12. Emerging drug targets for pain treatment. Eur J Pharmacol 2012 Apr 15; 681(1-3):1-5.

　　11. Effects of imidazoline I2 receptor agonists and morphine on schedule-controlled responding in rats. Pharmacol Biochem Behav 2012 May; 101(3):354-9.

　　10. Agmatine attenuates methamphetamine induced conditioned place preference in rats. Eur J Pharmacol 2012 Apr 5; 680(1-3):69-72.

　　9. Characterization of the hypothermic effects of imidazoline I2 receptor agonists in rats. Br J Pharmacol 2012 Jul; 166(6):1936-45.

　　8. Effects of imidazoline I2 receptor ligands on acute nociception in rats. NeuroReport 2012 Jan 25; 23(2):73-7.

　　7. Effects of imidazoline I2 receptor ligands on morphine- and tramadol-induced antinociception in rats. Eur J Pharmacol 2011 Nov 30; 670(2-3):435-40.

　　6. Morphine-induced antinociception in the rat: supra-additive interactions with imidazoline I2 receptor ligands. Eur J Pharmacol 2011 Nov 1; 669(1-3):59-65.

　　5. Eating high fat chow increases the sensitivity of rats to 8-OH-DPAT-induced lower lip retraction. Behav Pharmacol 2011 Dec; 22(8):751-7.

　　4. Imidazoline I2 receptors: target for new analgesics? Eur J Pharmacol 2011 May 11; 658(2-3):49-56.

　　3. Effects of serotonin (5-HT)1A and 5-HT2A receptor agonists on schedule-controlled responding in rats: drug combination studies. Psychopharmacology 2011 Feb; 213(2-3):489-97.

　　2. Effects of direct- and indirect-acting serotonin receptor agonists on the antinociceptive and discriminative stimulus effects of morphine in rhesus monkeys. Neuropsychopharmacology 2011 Apr; 36(5):940-9.

　　1. Differential effects of serotonin 5-HT1A receptor agonists on the discriminative stimulus effects of the 5-HT2A receptor agonist DOM in rats and monkeys. J Pharmacol Exp Ther 2010 Apr; 333(1):244-52.